Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 1 / 27
Slide 2 / 27
Page 1
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 3 / 27
Slide 4 / 27
Page 2
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 5 / 27
Slide 6 / 27
Page 3
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 7 / 27
Slide 8 / 27
Page 4
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 9 / 27
Slide 10 / 27
Page 5
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 11 / 27
Slide 12 / 27
Page 6
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 13 / 27
Slide 14 / 27
Page 7
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 15 / 27
Slide 16 / 27
Page 8
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 17 / 27
Slide 18 / 27
Page 9
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 19 / 27
Slide 20 / 27
Page 10
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 21 / 27
Slide 22 / 27
Page 11
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 23 / 27
Slide 24 / 27
Page 12
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 25 / 27
Slide 26 / 27
Page 13
undefined
S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett
Slide 27 / 27
Page 14